OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 10 citing articles:

Neoadjuvant systemic therapy for hepatocellular carcinoma
Robert C. Chick, Samantha M. Ruff, Timothy M. Pawlik
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8

Lymphocyte-activation gene 3 (LAG-3) as a promising immune checkpoint in cancer immunotherapy: From biology to the clinic
Yaser E. Alqurashi
Pathology - Research and Practice (2024) Vol. 254, pp. 155124-155124
Closed Access | Times Cited: 7

Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy
Salima Shebbo, Najat Binothman, Manar Darwaish, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7

Expression of immune checkpoint molecules TIGIT and TIM-3 by tumor-infiltrating lymphocytes predicts poor outcome in sinonasal mucosal melanoma
Stephan Ledderose, Carola Ledderose, Georg Ledderose
Pathology - Research and Practice (2024) Vol. 260, pp. 155468-155468
Open Access | Times Cited: 2

ImmunoPET imaging of LAG-3 expression in tumor microenvironment with68Ga-labelled cyclic peptides tracers: from bench to bedside
Ming Zhou, Bei Chen, Chenxi Lu, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e009153-e009153
Open Access | Times Cited: 2

Predictive and dynamic signature for anti-angiogenics in combination with PD-1 inhibitor in soft-tissue sarcoma: correlative studies linked to the IMMUNOSARC trial
David S. Moura, Jesús M. López Martí, Iva Benešová, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 22, pp. 5192-5206
Closed Access

An AI-driven preoperative radiomic subtype for predicting the prognosis and treatment response of patients with papillary thyroid carcinoma
Qiang Li, Weituo Zhang, Tian Liao, et al.
Clinical Cancer Research (2024) Vol. 31, Iss. 1, pp. 139-150
Closed Access

Mechanisms of immunotherapy resistance in small cell lung cancer
Yunan Nie, Kurt A. Schalper, Anne C. Chiang
Cancer Drug Resistance (2024)
Open Access

Page 1

Scroll to top